2BB score and signals
Tenaya Therapeutics, Inc.’s current 2BB score is 20 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 0 | Very Low |
| Momentum | 50 | Stable |
| Financial strength | 39 | Weak |
| Quality | 80 | Very Strong |
| Risk | 47 | Moderate |
Company facts
| Headquarters | South San Francisco, California, United States |
| Founded | 2016 |
| Employees | 70 |
| 52-week range | $0.53 – $2.35 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2026-11-02 | — | -0.1049 | — | $818,550.00 |
| 2026-08-12 | — | -0.0656 | — | $10.20M |
| 2026-05-06 | -0.09 | -0.0889 | $225,000.00 | $10.20M |
| 2026-03-11 | -0.12 | -0.1237 | $0.00 | $0.00 |
Related companies